Marshall Wace North America’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,367
| Closed | -$236K | – | 1625 |
|
|
2021
Q1 | $236K | Sell |
3,367
-6,336
| -65% | -$444K | ﹤0.01% | 1342 |
|
|
2020
Q4 | $582K | Buy |
+9,703
| New | +$582K | ﹤0.01% | 1051 |
|
|
2020
Q2 | – | Sell |
-24,752
| Closed | -$830K | – | 1392 |
|
|
2020
Q1 | $830K | Sell |
24,752
-71,773
| -74% | -$2.41M | 0.01% | 645 |
|
|
2019
Q4 | $4.37M | Buy |
96,525
+25,529
| +36% | +$1.16M | 0.02% | 413 |
|
|
2019
Q3 | $2.7M | Buy |
+70,996
| New | +$2.7M | 0.02% | 480 |
|
|
2019
Q2 | – | Sell |
-84,624
| Closed | -$3.22M | – | 1500 |
|
|
2019
Q1 | $3.22M | Buy |
+84,624
| New | +$3.22M | 0.02% | 398 |
|
|
2018
Q3 | – | Sell |
-32,571
| Closed | -$1.04M | – | 1257 |
|
|
2018
Q2 | $1.04M | Sell |
32,571
-36,747
| -53% | -$1.18M | 0.01% | 917 |
|
|
2018
Q1 | $2.16M | Sell |
69,318
-2,280
| -3% | -$71K | 0.01% | 796 |
|
|
2017
Q4 | $3.27M | Buy |
71,598
+56,623
| +378% | +$2.58M | 0.02% | 696 |
|
|
2017
Q3 | $569K | Sell |
14,975
-13,239
| -47% | -$503K | ﹤0.01% | 1048 |
|
|
2017
Q2 | $1.36M | Buy |
+28,214
| New | +$1.36M | 0.01% | 841 |
|